2016 American Transplant Congress
Conversion to Belatacept as Rescue Therapy in Kidney Transplant Recipients with Severe Graft Dysfunction.
Belatacept is a fusion protein that prevents T cell co-stimulation via the CD28 receptor. If used as first-line therapy, immunosuppression with Belatacept is associated with…2016 American Transplant Congress
Pediatric Kidney Transplantation and Mortality: Distance to Transplant Center Matters.
Surgery, Massachusetts General Hospital, Boston, MA.
INTRODUCTION: The distance traveled by adults to kidney transplant centers contributes to disparities in access and outcomes. We hypothesized that distance would adversely affect the…2016 American Transplant Congress
Sublingual Tacrolimus in Liver Transplantation: A Valid Option?
Introduction. Oral tacrolimus (Tac) is currently the pilar of maintenance immunosuppression following solid organ transplantation and the most common route of drug delivery. Recent studies…2016 American Transplant Congress
Economic Analysis of Survival for Patients Undergoing Kidney Transplant in a Philanthropic Hospital of Sao Paulo, Brazil.
Brazil has one of the most important public programs of transplant in the world. Our hospital is a private philanthropic that has already performed more…2016 American Transplant Congress
The Incidence, Risk Factors and Clinical Course of De Novo Hepatitis B Infection in Pediatric Living Donor Liver Transplantation.
Aim: We evaluated the incidence, risk factors and clinical course of liver transplanted pediatric patients with de novo hepatitis B infection and the clinical course…2016 American Transplant Congress
Identification of Donor HLA-Specific Antibodies as a Risk Factor for Graft Dysfunction and Failure Following BK Virus Associated Nephropathy.
Transplantation Medicine, Weill Cornell Medicine, New York, NY.
Background: BK virus associated nephropathy (BKVN) has emerged as a significant cause of graft dysfunction and graft failure. Identification of risk factors for graft dysfunction…2016 American Transplant Congress
Treatment of Post-Transplant Focal Glomerulosclerosis: The Effect on Histopathology Lesions and Podocyte Foot Process Effacement.
Background: Post-transplant Focal Segmental Glomerulosclerosis (FSGS) is associated with increased risk for renal allograft failure. It has been reported in the literature that podocyte foot…2016 American Transplant Congress
Stratifying Skin Versus Non-Skin Cancer Risk Post-Kidney Transplantation According to Patient Characteristics.
Introduction Cancer is a significant cause of morbidity and mortality after kidney transplantation but risk differs e.g. non-melanoma skin cancers have a better prognosis compared…2016 American Transplant Congress
Do Powerful Induction Antibodies Increase Post Renal Transplant Infections?
Transplant Institute, Tulane University School of Medicine, New Orleans, LA.
Purpose: Infection is one of the most common and costly complications of solid organ transplantation. Alemtuzemab (AL) is a powerful antibody that significantly reduced rejection…2016 American Transplant Congress
Hepatitis B Immune Globulin Withdrawal in HBsAg Positive Liver Transplant Patients.
Introduction: Liver transplantation for chronic hepatitis B virus (HBV) is associated with a high recurrence rate of HBV post-transplant without the use of prophylaxis. The…
- « Previous Page
- 1
- …
- 74
- 75
- 76
- 77
- 78
- …
- 180
- Next Page »